Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1991-6-10
|
pubmed:abstractText |
Several authors point to a different action of soluble insulin when mixed with a lente formulation containing either protamine or zinc. We evaluated glucose and insulin profiles in 17 type I diabetics, every one of whom was given what was considered the optimal amount of insulin twenty minutes before a standard evening meal. The patients were studied on two occasions, one week apart. According to a randomized sequence, those who received first the protamine-soluble mixture, took the Zn-soluble combination after one week and vice-versa. At the same time, we determined anti-insulin antibodies in order to rule out any different immunological interference, in the two moments of the study. Our results confirm that protamine-insulin given together with regular shows a serum insulin peak which is earlier and higher than that obtained with the corresponding mixture of Zn-insulin and regular (ANOVA: F = 5, 96; p = 0.02); blood glucose levels were lower with the former regimen, even though the difference did not reach statistical significance. Our conclusion is that Zn-containing insulin partly inactivates regular insulin when administered in the same syringe, and this may have an impact on the long-term treatment of the diabetic patient.
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin, Long-Acting,
http://linkedlifedata.com/resource/pubmed/chemical/Protamines,
http://linkedlifedata.com/resource/pubmed/chemical/Zinc,
http://linkedlifedata.com/resource/pubmed/chemical/insulin, neutral
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0009-9074
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
31
|
pubmed:volume |
136
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
95-100
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1827378-Adult,
pubmed-meshheading:1827378-Aged,
pubmed-meshheading:1827378-Analysis of Variance,
pubmed-meshheading:1827378-Blood Glucose,
pubmed-meshheading:1827378-Delayed-Action Preparations,
pubmed-meshheading:1827378-Diabetes Mellitus, Type 1,
pubmed-meshheading:1827378-Female,
pubmed-meshheading:1827378-Humans,
pubmed-meshheading:1827378-Insulin,
pubmed-meshheading:1827378-Insulin, Long-Acting,
pubmed-meshheading:1827378-Male,
pubmed-meshheading:1827378-Middle Aged,
pubmed-meshheading:1827378-Protamines,
pubmed-meshheading:1827378-Time Factors,
pubmed-meshheading:1827378-Zinc
|
pubmed:year |
1991
|
pubmed:articleTitle |
[Absorption of short-acting insulin mixed with different slow-release formulations].
|
pubmed:affiliation |
Divisione di Medicina, Ospedale Civile di Vigevano.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract,
Randomized Controlled Trial
|